Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Citrulline Supplementation in Sarcopenia for Severe COPD Patients
NCT03694964Unknown
- Sponsor
- CHU Grenoble Alpes
- Start
- Jan 2019
- Primary completion
- Jan 2019
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised, double-blind trial in chronic obstructive pulmonary disease (COPD) and Sarcopenia comparing Citrulline with Placebo (2 arms). Primary endpoint: Lean Body Mass at 45 days. Status: unknown.
02
Drugs
citrulline
03
Conditions
chronic obstructive pulmonary disease (COPD)Sarcopenia
Beyond the preview
Go deeper on NCT03694964.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03694964.